IMMUNE DEFICIENCY FOUNDATION

Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$18,802,131
Investments
69%
Cash & Equivalents
23%
Other Assets
5%
Prepaid Expenses
1%
Property, Plant, & Equipment (net)
<1%
Receivables (Non-Related)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$1,362,276
Other Liabilities
78%
Payables & Accruals
22%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$3,720,249
$4,337,655
+17%
Receivables (Non-Related)
$98,405
$83,166
-15%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$281,164
$218,864
-22%
Investments
$11,924,537
$13,010,733
+9%
Property, Plant, & Equipment (net)
$204,524
$187,238
-8%
Other Assets
$1,126,338
$964,475
-14%
Total Assets
$17,355,217
$18,802,131
+8%
Liabilities
2023
2024
Change
Payables & Accruals
$308,172
$298,983
-3%
Grants Payable
-
-
-
Deferred Revenue
$26,695
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,103,601
$1,063,293
-4%
Total Liabilities
$1,438,468
$1,362,276
-5%
Net assets
2023
2024
Change
Restricted Net Assets
$1,914,992
$885,704
-54%
Unrestricted Net Assets
$14,001,757
$16,554,151
+18%
Net assets
2023
2024
Change
Net assets
+$15,916,749
+$17,439,855
+10%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)